Industry News

The Government has awarded the University of Birmingham-hosted BactiVac Network up to £1 million funding to accelerate the development of bacterial vaccines in a bid to prevent infections occurring as part of the global fight against antimicrobial resistance (AMR).

The University of Birmingham and University Hospitals Birmingham NHS Foundation Trust (UHB) have launched a new study funded by The Drake Foundation to review and potentially enhance concussion diagnosis in Premier League football.

The University of Birmingham and Trinity College Dublin have launched a strategic research and education partnership which aims to strengthen European academic links and enhance collaborative research outputs.

When we remember a past event, the human brain reconstructs that experience in reverse order, according to a new study at the University of Birmingham.

Professor Ian Tomlinson, director of the Institute of Cancer and Genomic Sciences at the University of Birmingham, has teamed up with colleagues in the UK and Denmark to investigate whether early signs of bowel cancer can be spotted in people’s blood stream.

Researchers at the University of Birmingham have found two biomarkers that could be used to identify a heart condition known as atrial fibrillation in patients who have three ‘clinical risks’.

Scientists at the University of Birmingham have discovered a protein that could hold the key to novel gene therapies for skin problems including psoriasis – a common, chronic skin disease that affects over 100 million people worldwide.

The visual inspection of a suspicious skin lesion using the naked eye alone is not enough to ensure the accurate diagnosis of skin cancer, a group of experts have concluded following a largescale systematic review of research.

Researchers at the University of Birmingham are set to benefit from the largest IBM® POWER9™ Artificial Intelligence (AI) computer cluster in the UK.

GVA has been appointed by the University of Birmingham to find a development and funding partner for the £300 million Birmingham Life Sciences Park.